Heinz Schwer
Tracked across 2 events · 13 articles · First seen Jun 18, 2026 · Last active Jul 06, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Heinz Schwer, Chief Business Officer of VERAXA Biotech AG, highlighted the potential of the BiTAC-ADC platform to improve cancer treatment safety and efficacy.
Jun 18, 2026 · 6 articles
Business
Impact: Chief Business Officer Heinz Schwer comments on partnering environment and conference feedback.
Jul 06, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Heinz Schwer live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard